Denise Dignam - 01 Mar 2026 Form 4 Insider Report for Chemours Co (CC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 20:24:35 UTC
Prior SEC filing
26 Feb 2026
Next SEC filing
09 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Stein, Attorney-in-Fact

Key filing fact

Denise Dignam filed Form 4 for Chemours Co (CC) on 03 Mar 2026.

Key facts

  • This page summarizes Denise Dignam's Form 4 filing for Chemours Co (CC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 20:24.

Change

  • Previous filing in this sequence was filed on 26 Feb 2026.
  • Current net transaction value: -$405,293.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001848475 Primary reporting owner

Dignam Denise

Relationship
Chief Executive Officer, Director
Address
C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON
Signature
/s/ Eric Stein, Attorney-in-Fact
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Tax liability

Transaction value
$405,293
Shares
-22,220
Change %
-12%
Price
$18.24
Shares after
165,776
Date
01 Mar 2026
Ownership
Direct
Footnotes
F1
CC transaction

Common Stock

Award

Transaction value
$0
Shares
+169,538
Change %
+102%
Price
$0.000000
Shares after
335,314
Date
02 Mar 2026
Ownership
Direct
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares automatically withheld to satisfy tax obligations on vesting restricted stock units ("RSUs") and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

Footnote F2

RSU award scheduled to vest in three equal annual installments beginning on March 1, 2027.

Footnote F3

Includes directly owned shares, RSUs and dividend equivalent units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .